Dasolampanel etibutil

DB12049InvestigationalSmall molecule

Dasolampanel etibutil has been used in trials studying the treatment of Diabetic Neuropathy, Painful.

Mechanism: Pharmacologically active on Metabotropic glutamate receptor 5
Curator reviewed
Formula / weight: C₂₃H₃₂ClN₅O₃ · 461.99 g/mol (avg)
Code names: LY-545694

Resolves to

Compound

Structure

InChIKeyHPBRMCFZIGUGTK-ZMMAXQRCSA-NSMILESCCC(CC)COC(=O)[C@@H]1C[C@H]2C[C@H](CC[C@H]2CN1)OC1=CC=CC(Cl)=C1C1=NN=NN1

Targets

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

2Clinical trialsPhase, status and sponsor resolved per trial

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with Dasolampanel etibutil, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.